[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100443492":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":19,"responsibleParty":32,"collaborators":10,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":36,"sex":42,"minAge":43,"maxAge":10,"enrollmentInfo":44,"targetDuration":10,"studyType":47,"phases":10,"briefSummary":48,"conditions":49,"keywords":10,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"Centre Hospitalier Universitaire Dijon","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient with WOVEX bifurcated prosthesis",null,"* Patients who have undergone open abdominal aortic surgery between January 1st, 2013 and December 31, 2017 in Burgundy Dijon Hospital.\n* Patients who have been treated with a WOVEX bifurcated prosthesis (Wovex® Polyester Vascular Protheses)",[13],"Other: Data collection",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Data collection","demographics co-morbidities risk factors operative, hospital and vascular follow-up data",[9],[20],{"facility":21,"status":10,"city":22,"state":10,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":10},"Chu Dijon Bourogne","Dijon","21000","France","FR",{"type":27,"coordinates":28},"Point",[29,30],5.01391,47.31344,{"lat":30,"lon":29},{"type":33,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100443492","post-market-clinical-follow-up-of-wovex-wovex-polyester-vascular-prostheses-bifurcated-prostheses-from-lemaitre-vascular-society-in-the-treatment-of-aneurysms-or-occlusive-diseases-of-the-abdominal-aorta-100443492",false,"NCT05055102","Post-Market Clinical Follow-up of WOVEX (Wovex® Polyester Vascular Prostheses) Bifurcated Prostheses From LEMAITRE VASCULAR Society in the Treatment of Aneurysms or Occlusive Diseases of the Abdominal Aorta.","Post-Market Clinical Follow-up of WOVEX (Wovex® Polyester Vascular Prostheses) Bifurcated Prostheses From LEMAITRE VASCULAR Society in the Treatment of Aneurysms or Occlusive Diseases of the Abdominal Aorta","WOBIF","Inclusion Criteria:\n\n* Subject is volontarily agree to participation\n* Patients operated for aneurysms or occlusive disease of the abdominal aorta at Dijon Bourgogne University Hospital between January, 1st 2013 and December 31, 2017 who received a WOVEX bifurcated prosthesis (Wovex® Polyester Vascular Protheses) from LEMAITRE VASCULAR Society\n\nExclusion Criteria:\n\n\\- Deceased patients who have expressed their refusal of post-mortem processing of their personal health data","ALL","18 Years",{"count":45,"type":46},173,"ACTUAL","OBSERVATIONAL","The Wovex bifurcated dacron vascular prostheses have been available on the French market since 2008. They are mainly used to treat aneurysmal or occlusive aortic diseases. To date, they have not been the subject of a specific clinical efficacy\u002Fsafety study, unlike other Dacron prostheses used in the same field.\n\nWe purpose a monocentric, retrospective, consecutive study based on medical data, including all the patients operated for aneurysms or occlusive disease of the abdominal aorta at Dijon Bourgogne University Hospital between 2013 and 2017 and who received a WOVEX bifurcated prosthesis (Wovex® Polyester Vascular Protheses).\n\nThe objective is to explore the safety (short-term postoperative morbidity and mortality at 5 years) and efficacy (primary permeability, secondary permeability and dilatation of the prosthesis at 5 years) of the WOVEX prosthesis.",[50],"Aneurysms or Occlusive Disease of the Abdominal Aorta","COMPLETED","2021-09-14",{"date":54,"type":46},"2021-09-24",{"date":56,"type":46},"2021-01-16",{"date":58,"type":46},"2021-08-31",{"name":5,"class":6},1]